Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform
- 17 July 1996
- journal article
- Published by Elsevier in Toxicology
- Vol. 111 (1-3) , 289-303
- https://doi.org/10.1016/0300-483x(96)03383-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Sensitivity of Physiologically Based Pharmacokinetic Models to Variation in Model Parameters: Methylene ChlorideRisk Analysis, 1994
- Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testingToxicology Letters, 1993
- Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)Toxicology Letters, 1993
- Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 miceFundamental and Applied Toxicology, 1993
- Improvements in Quantitative Noncancer Risk Assessment Sponsored by the Risk Assessment Specialty Section of the Society of ToxicologyFundamental and Applied Toxicology, 1993
- Development of a physiologically based pharmacokinetic model for chloroformToxicology and Applied Pharmacology, 1990
- Precision and sensitivity of pharmacokinetic models for cancer risk assessment: Tetrachloroethylene in mice, rats, and humansToxicology and Applied Pharmacology, 1990
- Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in outputToxicology Letters, 1989
- Integrating Uncertainty and Interindividual Variability in Environmental Risk AssessmentRisk Analysis, 1987
- Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 miceFundamental and Applied Toxicology, 1985